Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL

NCT06195735 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT06195735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06195735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL
Lead sponsor
Aarhus University Hospital
Phase
Observational
Overall status
Completed
Start date
July 17, 2020
Completion date
December 21, 2023
Enrollment
649 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia